Article
Genotypic and functional diversity of phenotypically defined primitive hematopoietic cells in patients with chronic myeloid leukemia.
Experimental hematology - 1 Oct 2013
Sloma Ivan, Beer Philip A, Saw Kyi Min, Chan Matthew, Leung Donna, Raghuram Kamini, Brimacombe Cedric, Johnston Bobby, Lambie Karen, Forrest Donna, Jiang Xiaoyan, Eaves Connie J
Abstract excerpt
Much progress has been made in the management of chronic-phase chronic myeloid leukemia (CP-CML), but there is a continuing imperative to develop curative treatments, predict patient responses to specific modalities, and anticipate disease relapse or progression. These needs underlie continuing interest in methods to detect and quantify the relevant leukemic cells in clinical samples with improved reliability and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
